Literature DB >> 7260061

Thermodynamic and molecular basis for dissimilar cholesterol-solubilizing capacities by micellar solutions of bile salts: cases of sodium chenodeoxycholate and sodium ursodeoxycholate and their glycine and taurine conjugates.

M C Carey, J C Montet, M C Phillips, M J Armstrong, N A Mazer.   

Abstract

The bile salts chenodeoxycholate (CDC) and its 7 beta-hydroxy epimer ursodeoxycholate (UDC) are administered therapeutically (as acids) to dissolve cholesterol gallstones in man. Since their micellarr solutions and those of their physiological conjugates differ strikingly in their capacities to solubilize cholesterol, we studied the interfacial and micellar properties of the epimers by a number of complimentary physical--chemical methods and correlated these with their solubilizing capacities. The critical micella concentrations (cmc) estimated by surface tension, dye titration, and turbidimetry were similar (1-5 mM), varying slightly with the bile salt species, the method employed, NaCl concentration (0-1 M), and temperature (10-50 degrees C). The weight-average aggregation number (number of monomers per micelle, nw) at the cmc, derived from Debye plots of conventional light-scattering data and from the mean hydrodynamic radii of the micelles obtained by quasi-elastic light-scattering spectroscopy, revealed no appreciable differences between the UDC-CDC epimers or between their conjugates. From the mean hydrodynamic radii, the taurine conjugates were found to form larger micelles (nw = 15-17) than the glycine conjugates (nw = 13) which in turn were larger than the free species (n w = 5), respectively. Consistent with previous experimental deductions, free and conjugated CDC micelles grew slightly in size with increases in total lipid concentration, but UDC micelles did not. With solubilization of cholesterol monohydrate, the mean sizes of UDC (13.4 A) and of CDC (13 A) micelles in 10 g/dL solutions did not change appreciably, even as the cholesterol saturation limit was reached. At the air-5 M NaCl (pH 2) interface, the glycine conjugates formed more expanded monomolecular films than the free acid, and both UDC and its glycine conjugate collapsed at surface pressures that were 10-20 mN m-1 lower than the collapse pressures of monolayers of CDC and its glycine conjugate. Similarly, adsorbed monolayers of ionized UDC and its taurine conjugate lowered the surface tension of water approximately 5 mN m-1 less than equimolar concentrations of CDC and its taurine conjugate. By employing high-performance reversed-phase liquid chromatography (HPLC), we measured the relative hydrophilic--hydrophobic properties of the bile salts and found a close correlation between HPLC mobility and cholesterol-solubilizing cpacity. Assuming a single cholesterol binding site per micelle, we estimated from the nw values and bile salt/cholesterol saturation ratios that the magnitude of the cholesterol binding constant (K) was 5.7 X 10(6) L/mol for unconjugated CDC and 2.5 X 10(5) L/mol for unconjugated UDC at 30 degrees C. These results suggest that the differences in cholesterol-solubilizing capacities of CDC and UDC and their conjugates are due to subtle differences in micellar structure, resulting from the axial or equatorial orientation of the 7-hydroxyl function and the various conjugating groups...

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7260061     DOI: 10.1021/bi00515a052

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  11 in total

Review 1.  Ursodeoxycholic acid in the treatment of cholesterol cholelithiasis. Part II.

Authors:  W H Bachrach; A F Hofmann
Journal:  Dig Dis Sci       Date:  1982-09       Impact factor: 3.199

Review 2.  Therapeutic uses of animal biles in traditional Chinese medicine: an ethnopharmacological, biophysical chemical and medicinal review.

Authors:  David Q-H Wang; Martin C Carey
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

3.  Effect of indomethacin on bile acid-phospholipid interactions: implication for small intestinal injury induced by nonsteroidal anti-inflammatory drugs.

Authors:  Yong Zhou; Elizabeth J Dial; Rand Doyen; Lenard M Lichtenberger
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-03-04       Impact factor: 4.052

4.  Solubilization of lipids from hamster bile-canalicular and contiguous membranes and from human erythrocyte membranes by conjugated bile salts.

Authors:  J M Graham; T C Northfield
Journal:  Biochem J       Date:  1987-03-15       Impact factor: 3.857

5.  Stabilization of biliary lipid particles by ursodeoxycholic acid. Prolonged nucleation time in human gallbladder bile.

Authors:  S Mizuno; S Tazuma; G Kajiyama
Journal:  Dig Dis Sci       Date:  1993-04       Impact factor: 3.199

6.  Nasal absorption of insulin: enhancement by hydrophobic bile salts.

Authors:  G S Gordon; A C Moses; R D Silver; J S Flier; M C Carey
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

Review 7.  Ursodeoxycholic acid: a review of its pharmacological properties and therapeutic efficacy.

Authors:  A Ward; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-02       Impact factor: 9.546

8.  Improvement of cyclosporin A-induced cholestasis by tauroursodeoxycholate in a long-term study in the rat.

Authors:  P E Queneau; P Bertault-Peres; M Guitaoui; E Mesdjian; A Durand; J C Montet
Journal:  Dig Dis Sci       Date:  1994-07       Impact factor: 3.199

9.  Spectrophotometric determination of the critical micellar concentration of bile salts using bilirubin monoglucuronide as a micellar probe. Utility of derivative spectroscopy.

Authors:  W Spivak; C Morrison; D Devinuto; W Yuey
Journal:  Biochem J       Date:  1988-05-15       Impact factor: 3.857

10.  Effect of taurochenodeoxycholate or tauroursodeoxycholate upon biliary output of phospholipids and plasma-membrane enzymes, and the extent of cell damage, in isolated perfused rat livers.

Authors:  S G Barnwell; P J Lowe; R Coleman
Journal:  Biochem J       Date:  1983-10-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.